Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The drug, being developed for a rare genetic disorder and currently under review in the U.S., is seen by some investors as ...

We recently published a list of Jim Cramer Recently Talked About These 15 Stocks. In this article, we are going to take a ...

We recently published a list of 11 Best Guru Stocks to Buy According to Wall Street Analysts. In this article, we are going ...

EDT Biohaven (BHVN) down 12% to $20.60 after pulling European applicationStay Ahead of the Market: Discover outperforming stocks and ...

EDT Biohaven (BHVN) trading halted, volatility trading pauseStay Ahead of the Market: Discover outperforming stocks and invest smarter ...

Investing.com -- Biohaven Pharma (NYSE: BHVN) shares fell sharply by as much as 21% as the company withdrew its marketing authorization application for Dazluma in Europe, intended to treat ...

That news came not from Biohaven itself, but from the European Medicines Agency (EMA, the pharmaceutical regulator for the 27-country European Union). In a statement, the EMA revealed that a ...

In this article, we are going to take a look at where Biohaven Ltd. (NYSE:BHVN) stands against other Guru stocks to invest in. Wall Street seems to be breathing a little easier after the initial ...